Multiple Sclerosis Research Repository


“Should ocrelizumab be used in non-active primary progressive multiple sclerosis? Time for a re-assessment”:

Navid Manouchehri and Olaf Stüve

https://journals.sagepub.com/doi/10.1177/1756286421990500?icid=int.sj-abstract.citing-articles.33

Published by


Leave a comment